Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Imaging approach in radioimmunodetection

F H DeLand, E E Kim, G Simmons

Cancer Research

|August 1, 1980

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.

European journal of nuclear medicine and molecular imaging·2020

Same author

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses.

Human vaccines & immunotherapeutics·2017

Same author

Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumors.

Bioconjugate chemistry·2014

This study introduces a novel processing method to enhance tumor imaging using radioactively labeled antibodies. The technique improves tumor detection rates by reducing background noise from nontarget radioactivity.

Area of Science:

Oncology
Radiochemistry
Medical Imaging

Background:

External in vivo imaging of tumors using radioactively labeled antibodies is crucial for diagnosis and monitoring.
Interfering nontarget radioactivity can significantly reduce image quality and diagnostic accuracy.
Accurate tumor detection relies on maximizing the signal from targeted antibodies against background noise.

Purpose of the Study:

To develop and validate a processing method for reducing nontarget radioactivity in tumor imaging.
To improve the target-to-nontarget radioactivity ratio for enhanced tumor visualization.
To increase the overall tumor detection rate in external in vivo imaging studies.

Main Methods:

Utilizing simulated nontarget compounds labeled with a physically distinct radionuclide.

Related Experiment Videos

Administering radioactively labeled antibodies targeting tumor-associated antigens.

Subtracting the signal from simulated nontarget compounds from the overall signal to isolate tumor-specific activity.

Main Results:

Achieved a 2-fold increase in the target-to-nontarget radioactivity ratio.
Demonstrated a significant reduction in interfering nontarget radioactivity.
Enabled a tumor detection rate exceeding 70%.

Conclusions:

The developed processing method effectively enhances tumor imaging by mitigating background radioactivity.
This technique offers a significant improvement in diagnostic capabilities for tumor detection.
The improved target-to-nontarget ratio is key to achieving high tumor detection rates in vivo.